173 related articles for article (PubMed ID: 22114725)
1. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization.
Stein P; Weber M; Prüfer S; Schmid B; Schmitt E; Probst HC; Waisman A; Langguth P; Schild H; Radsak MP
PLoS One; 2011; 6(11):e27911. PubMed ID: 22114725
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection.
Warger T; Rechtsteiner G; Schmid B; Osterloh P; Schild H; Radsak MP
Clin Rev Allergy Immunol; 2007 Feb; 32(1):57-66. PubMed ID: 17426361
[TBL] [Abstract][Full Text] [Related]
4. Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization.
Rausch J; Lopez PA; Bialojan A; Denny M; Langguth P; Probst HC; Schild H; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):300-306. PubMed ID: 28666747
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10.
Ghoreishi M; Dutz JP
J Immunol; 2006 Feb; 176(4):2635-44. PubMed ID: 16456026
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod.
Rechtsteiner G; Warger T; Osterloh P; Schild H; Radsak MP
J Immunol; 2005 Mar; 174(5):2476-80. PubMed ID: 15728450
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation.
Stein P; Gogoll K; Tenzer S; Schild H; Stevanovic S; Langguth P; Radsak MP
PLoS One; 2014; 9(7):e102664. PubMed ID: 25025233
[TBL] [Abstract][Full Text] [Related]
8. UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin.
Stein P; Rechtsteiner G; Warger T; Bopp T; Fuhr T; Prüfer S; Probst HC; Stassen M; Langguth P; Schild H; Radsak MP
J Invest Dermatol; 2011 Jan; 131(1):211-9. PubMed ID: 20739947
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors.
Dell K; Koesters R; Gissmann L
Int J Cancer; 2006 Jan; 118(2):364-72. PubMed ID: 16052529
[TBL] [Abstract][Full Text] [Related]
10. 9-Phenanthrol enhances the generation of an CD8
Hartmann AK; Aranda Lopez P; Zajac M; Freichel M; Schild H; Radsak MP; Stassen M
J Dermatol Sci; 2017 Sep; 87(3):260-267. PubMed ID: 28823644
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice.
Bialojan A; Sohl J; Rausch J; Aranda Lopez P; Denny M; Langguth P; Hartmann AK; Yagita H; Probst HC; Schild H; Radsak MP
Eur J Immunol; 2019 Nov; 49(11):2083-2094. PubMed ID: 31393597
[TBL] [Abstract][Full Text] [Related]
12. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
13. Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Hartmann AK; Bartneck J; Pielenhofer J; Meiser SL; Arnold-Schild D; Klein M; Stassen M; Schild H; Muth S; Probst HC; Langguth P; Grabbe S; Radsak MP
Front Immunol; 2023; 14():1238861. PubMed ID: 37727790
[TBL] [Abstract][Full Text] [Related]
14. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.
Clark RA; Huang SJ; Murphy GF; Mollet IG; Hijnen D; Muthukuru M; Schanbacher CF; Edwards V; Miller DM; Kim JE; Lambert J; Kupper TS
J Exp Med; 2008 Sep; 205(10):2221-34. PubMed ID: 18794336
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis.
Zhao J; Zhao J; Fett C; Trandem K; Fleming E; Perlman S
J Exp Med; 2011 Aug; 208(8):1571-7. PubMed ID: 21746812
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
17. Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization.
Hosoi A; Takeda Y; Furuichi Y; Kurachi M; Kimura K; Maekawa R; Takatsu K; Kakimi K
Cancer Res; 2008 May; 68(10):3941-9. PubMed ID: 18483280
[TBL] [Abstract][Full Text] [Related]
18. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice.
Heib V; Becker M; Warger T; Rechtsteiner G; Tertilt C; Klein M; Bopp T; Taube C; Schild H; Schmitt E; Stassen M
Blood; 2007 Aug; 110(3):946-53. PubMed ID: 17446350
[TBL] [Abstract][Full Text] [Related]
19. UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses.
Toda M; Wang L; Ogura S; Torii M; Kurachi M; Kakimi K; Nishikawa H; Matsushima K; Shiku H; Kuribayashi K; Kato T
Int J Cancer; 2011 Sep; 129(5):1126-36. PubMed ID: 21710495
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
